Company information lookup

Go

View full list of companies

SIRTEX MEDICAL LIMITED (SRX)

Research and commercial development of treatments for liver cancer

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options 		ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
SRX 10.980 1.1% 10.800 10.990 10.750 11.110 10.750 192,320

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

SIRTEX MEDICAL LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code SRX
Securities
Official Listing Date 24 August, 2000
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.sirtex.com
Registered Office Address Level 33, 101 Miller Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Head Office Telephone (02) 9964 8400
Head Office Fax (02) 9964 8410
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Richard Hill (Chairman)
Dr John Eady (Deputy Chairman, Non Exec. Director)
Mr Gilman Wong (CEO, Director)
Mr Grant Boyce (Non Exec. Director)
Mr Darren Smith (CFO)
Company Secretary Mr Darren Smith
Principal Activities Research and commercial development of treatments for liver cancer

SIRTEX MEDICAL LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.		 Headline Pages PDF
03/05/2013   Change in substantial holding from SRX 8 PDF
26/04/2013   Ceasing to be a substantial holder 3 PDF
23/04/2013   Becoming a substantial holder 13 PDF
12/04/2013 asterix Sirtex Completes SIRFLOX Patient Recruitment 1 PDF
09/04/2013   Change in substantial holding from PPT 8 PDF
09/04/2013   Ceasing to be a substantial holder 2 PDF
05/04/2013 asterix Third Quarter Dose Sales 1 PDF
04/03/2013   Half Year Results Presentation December 2012 28 PDF
14/02/2013 asterix Half Yearly Report and Accounts 20 PDF
04/02/2013   Change in substantial holding 3 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 May 2013 10.980 1.1% 11.110 10.750 192,320
16 May 2013 10.860 3.43% 10.940 10.750 451,846
15 May 2013 10.500 -1.87% 11.000 10.330 289,533
14 May 2013 10.700 -2.55% 11.100 10.670 154,064
13 May 2013 10.980 2.14% 11.250 10.750 314,146

* Volume of shares shown represents only those shares traded on ASX.

SIRTEX MEDICAL LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

Code Div Amount Ex Div Date Record Date Date Payable % Franked Type Further Information
SRX 10c 08/10/2012 12/10/2012 26/10/2012 100% Final 10C FRANKED @ 30%

Exchange Traded Options

No Exchange Traded Options are available over the security SRX

Warrants & Structured Products

Warrants & Structured Products are available over the security SRX. Click here to view the current warrant issue details.

ASX CFDs

No Contracts For Differences are available over the security SRX